Home › Funds › Royce & Associates › CDRE
Royce & Associates position in CDRE
CADRE HLDGS INC · Health Care
Latest position (Q3 2023)159.94K sh
Reported value held$4.26M
Portfolio Weight0.04%
First reportedQ4 2021
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 265.20K | $6.74M | New |
| Q1 2022 | 241.50K | $5.93M | Reduce |
| Q2 2022 | 220.21K | $4.33M | Reduce |
| Q3 2022 | 199.00K | $4.79M | Reduce |
| Q4 2022 | 140.34K | $2.83K | Reduce |
| Q1 2023 | 151.24K | $3.26K | Add |
| Q2 2023 | 159.94K | $3.49M | Add |
| Q3 2023 | 159.94K | $4.26M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CDRE
- BlackRock Inc 2.94M sh · $83.73M · Q2 2026
- Fidelity Management & Research (FMR) 2.48M sh · $70.58M · Q2 2026
- Vanguard Group 1.67M sh · $68.25M · Q4 2025
- Capital World Investors 1.21M sh · $34.36M · Q2 2026
- Geode Capital Management 773.52K sh · $22.06M · Q2 2026
- Morgan Stanley 729.64K sh · $20.80M · Q2 2026
- Capital Research Global Investors 686.03K sh · $19.56M · Q2 2026
- Bank of America Corp 665.87K sh · $18.98M · Q2 2026
- Invesco Ltd 333.17K sh · $9.50M · Q2 2026
- First Eagle Investment Management 306.46K sh · $8.74M · Q2 2026
- Northern Trust Corp 298.94K sh · $8.52M · Q2 2026
- Charles Schwab Investment Management 252.15K sh · $7.19M · Q2 2026